Results 311 to 320 of about 7,106,023 (372)

Artificial intelligence-driven clinical decision support systems to assist healthcare professionals and people with diabetes in Europe at the point of care: a Delphi-based consensus roadmap. [PDF]

Diabetologia
Bajramagic M, Battelino T, Cos X, Cote M, Cui N, Forbes A, Galderisi A, Heinemann L, Hussain S, Imbert J, Holm Jönsson C, Joubert M, Lalić NM, Phillip M, Schwarz P, Torbeyns B, Wake DJ, Zakrzewska K, Del Prato S.   +18 more
europepmc   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Trust in Artificial Intelligence-Based Clinical Decision Support Systems Among Health Care Workers: Systematic Review.

J Med Internet Res
Tun HM, Rahman HA, Naing L, Malik OA.
europepmc   +1 more source

The implementation challenge of computerised clinical decision support systems for the detection of disease in primary care: systematic review and recommendations. [PDF]

Implement Sci
Derksen C, Walter FM, Akbar AB, Parmar AVE, Saunders TS, Round T, Rubin G, Scott SE.   +7 more
europepmc   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Chat GPT vs. Clinical Decision Support Systems in the Analysis of Drug-Drug Interactions. [PDF]

Clin Pharmacol Ther
Bischof T, Al Jalali V, Zeitlinger M, Jorda A, Hana M, Singeorzan KN, Riesenhuber N, Stemer G, Schoergenhofer C.   +8 more
europepmc   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

[AI-enabled clinical decision support systems: challenges and opportunities]. [PDF]

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
Tschochohei M, Adams LC, Bressem KK, Lammert J.   +3 more
europepmc   +1 more source

Digitization in nursing processes and the use of clinical decision support systems: do they improve perinatal indicators? [PDF]

BMC Pregnancy Childbirth
Özkan A, Acar Z.
europepmc   +1 more source

Implementation of artificial intelligence-based decision support systems for antibiotic prescribing in hospitals: a Delphi study. [PDF]

Front Digit Health
Tokgöz P, Albrecht J, Dockweiler C.
europepmc   +1 more source